Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Summary

This is an open-label, non-randomized study to evaluate the safety of two planned infusions of BPX-501 T cells after partially mismatched, related (haploidentical) HSCT in adults with hematologic malignancies.

Timeline

Start

2016-07

Primary completion

2017-06

Completion

2017-06

Drugs

Indications